Skip to Main Content

An inherited disorder caused by androgen insensitivity with affected males having a female phenotype with normal female external genitalia but abnormal or absent internal female organs. Testes are often intraabdominal, in the inguina, or in the labia. Normal male (46,XY) karyotype.

Testicular Feminization; Androgen Receptor Deficiency; Dihydrotestosterone Receptor Deficiency; Male Pseudohermaphroditism as a Result of Androgen Insensitivity; Hairless Women Syndrome.

Estimates vary from 1:7,000-20,000 male live births. No racial predilection has been reported.

X-linked recessive with the responsible gene encoding for the androgen receptor being located on Xq11-q12. More than 200 different mutations have been described.

The basic etiology of androgen insensitivity syndrome (AIS) is a mutation in the androgen receptor gene that results in the gene's loss of function. The functional defects can range from complete absence of receptors on the cell surface to decreased substrate binding affinity with loss of signal transmission. Despite normal or elevated levels of androgen, functional loss of the androgen receptor is clinically equivalent to a lack of androgen and results in prenatal undervirilization of external genitalia, and absence of pubic and axillary hair, lack of acne, and absence of voice changes at puberty. Leydig cell stimulation to estrogen production occurs probably because of a failure in feedback repression of the pituitary gland, which shares the unresponsiveness to androgen. Peripheral conversion of testosterone and androstenedione to estradiol finally results in elevated estrogen serum levels. This on the one hand explains the absence of (androgen mediated) axillary and pubic hair, acne, and voice changes and on the other hand the development of normal breasts in these patients.

The clinical findings of inguinal hernia with a labial mass in infancy and primary amenorrhea despite typical female secondary sex characteristics, but scant or absent pubic and axillary hair in puberty should raise suspicion for AIS. Affected males have female external genitalia associated with normal or high testosterone serum levels. In infancy, plasma luteinizing hormone (LH) and testosterone levels and the response to luteinizing hormone-releasing hormone (LHRH) are higher than in age-matched controls. In puberty, the androgen insensitivity, which also affects the hypothalamic-pituitary area, results in elevated testicular androgen and estradiol synthesis.

These genotypic male patients are phenotypic females. Anatomically, they have normal female external genitalia but a blind-ending vaginal pouch and absent uterus and fallopian tubes. The testes usually are located intraabdominally, in the inguinal canal, or in the labia. Leydig cells appear hyperplastic and form adenomatous clumps. Primary amenorrhea and scant pubic and axillary hair contrast with well developed female personality and body shape (including breasts). Patients often appear tall for females, and the clinical signs result from high estrogen levels. Other features include inguinal hernia and an increased risk of testicular malignancies (Sertoli cell adenomas, seminomas, malignant sex-cord stromal tumor) after 25 years of age. Patients often present for orchiectomy and vaginal lengthening procedures, both now often done at the end of ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.